(Q46248484)

English

Are migraineurs at increased risk of adverse drug responses? A meta-analytic comparison of topiramate-related adverse drug reactions in epilepsy and migraine

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18987621

0 references

Are migraineurs at increased risk of adverse drug responses? A meta-analytic comparison of topiramate-related adverse drug reactions in epilepsy and migraine (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18987621

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

object named as

M D Ferrari

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

author name string

J Luykx

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18987621

M Mason

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18987621

J Carpay

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18987621

language of work or name

0 references

publication date

5 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18987621

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18987621

85

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18987621

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18987621

283-288

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18987621

https://scigraph.springernature.com/pub.10.1038/clpt.2008.203

0 references

Epilepsy and migraine

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

Epilepsy and migraine: The dopamine hypotheses

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

Neurological disorders caused by inherited ion-channel mutations

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

Topiramate for migraine prevention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

Topiramate in migraine prevention: results of a large controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

Topiramate in the Treatment of Chronic Migraine

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

Randomized dose-controlled study of topiramate as first-line therapy in epilepsy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

Topiramate monotherapy for partial onset seizures.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

Topiramate for treating alcohol dependence: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

Topiramate slow dose titration: improved efficacy and tolerability

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

Reporting of adverse drug reactions in randomised controlled trials - a systematic survey

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

An association between migraine and cutaneous allodynia.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

Treatment-emergent CNS symptoms following triptan therapy are part of the attack

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

The efficacy of conservative treatment in patients with whiplash injury: a systematic review of clinical trials.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

21 January 2018

Low dose and slow titration of topiramate as adjunctive therapy in refractory partial epilepsies: a multicentre open clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.203

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CLPT.2008.203

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18987621

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18987621

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46248484&oldid=2102134923"